|
|
| | ANTI-HUMAN IL-5 Basic information |
| Product Name: | ANTI-HUMAN IL-5 | | Synonyms: | RAT ANTI-HUMAN IL-5;RABBIT ANTI-HUMAN IL-5;RABBIT ANTI-HUMAN INTERLEUKIN-5;ANTI-HUMAN BCDFII;ANTI-HUMAN EDF;ANTI-HUMAN INTERLEUKIN-5;ANTI-HUMAN IL-5;ANTI-HUMAN IL-5 POLYCLONAL ANTIBODY | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![ANTI-HUMAN IL-5 Structure]() |
| | ANTI-HUMAN IL-5 Chemical Properties |
| storage temp. | -20°C | | form | lyophilized powder |
| | ANTI-HUMAN IL-5 Usage And Synthesis |
| Uses | Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunohistochemistry (1 paper) | | General Description | INHBA (Inhibin, β A) is a morphogen belonging to the TGFβ superfamily. It encodes a protein reffered to as activin A. It is expressed in both α- and β-cells of pancreatic islets. It is composed of two nearly anti-parallel activin A monomers separated by a 2-fold symmetry axis. Each monomer consists of the canonical TGF-β fold. | | Biochem/physiol Actions | INHBA (Inhibin, β A) is associated with various cellular activities such as cell differentiation, proliferation, activation and apoptosis. It has binding affinity for both the type I and type II serine/threonine kinase receptors. INHBA directly binds to the extracellular domain of the type II receptor, ActRIIB, which further adhere to the outer edges of the activin finger regions. It controls genetic expression of islet β cells. In non-small cell lung cancer (NSCLC), it acts as an autocrine factor in the maintenance of mesenchymal properties of cancer-initiating cells (CICs) to promote metastasis. |
| | ANTI-HUMAN IL-5 Preparation Products And Raw materials |
|